» Articles » PMID: 16364302

P70 S6 Kinase Mediates Tau Phosphorylation and Synthesis

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2005 Dec 21
PMID 16364302
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, we found that the 70-kDa p70 S6 kinase (p70S6K) directly phosphorylates tau at S262, S214, and T212 sites in vitro. By immunoprecipitation, p-p70S6K (T421/S424) showed a close association with p-tau (S262 and S396/404). Zinc-induced p70S6K activation could only upregulate translation of total S6 and tau but not global proteins in SH-SY5Y cells. The requirement of p70S6K activation was confirmed in the SH-SY5Y cells that overexpress wild-type htau40. Level of p-p70S6K (T421/S424) was only significantly correlated with p-tau at S262, S214, and T212, but not T212/S214, in Alzheimer's disease (AD) brains. These suggested that p70S6K might contribute to tau related pathologies in AD brains.

Citing Articles

Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice.

Barbour A, Gourmaud S, Lancaster E, Li X, Stewart D, Hoag K Brain. 2024; 147(6):2169-2184.

PMID: 38662500 PMC: 11146435. DOI: 10.1093/brain/awae126.


Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer's Disease-Related Epitopes and Increases Intraneuronal Tau Levels.

Garcia-Cruz V, Arias C Mol Neurobiol. 2024; 61(8):5129-5141.

PMID: 38167971 PMC: 11249523. DOI: 10.1007/s12035-023-03886-8.


Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.

Saresella M, Zoia C, La Rosa F, Bazzini C, Sala G, Grassenis E Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139851 PMC: 10747596. DOI: 10.3390/ph16121725.


Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).

de la Monte S J Alzheimers Dis. 2023; 95(4):1301-1337.

PMID: 37718817 PMC: 10896181. DOI: 10.3233/JAD-230555.


Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688.

Bellissimo C, Castellani L, Finch M, Murugathasan M, Gandhi S, Sweeney G Exp Physiol. 2023; 108(9):1108-1117.

PMID: 37415288 PMC: 10988430. DOI: 10.1113/EP091274.